Pathstone Family Office’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.02M | Buy |
10,937
+7,807
| +249% | +$728K | 0.01% | 696 |
|
|
2023
Q2 | $448K | Buy |
3,130
+282
| +10% | +$40.4K | 0.01% | 796 |
|
|
2023
Q1 | $331K | Sell |
2,848
-15,524
| -84% | -$1.8M | 0.01% | 873 |
|
|
2022
Q4 | $1.41M | Buy |
18,372
+7,465
| +68% | +$574K | 0.01% | 621 |
|
|
2022
Q3 | $878K | Buy |
+10,907
| New | +$878K | 0.01% | 807 |
|
|
2021
Q1 | – | Sell |
-56
| Closed | -$5K | – | 832 |
|
|
2020
Q4 | $5K | Buy |
+56
| New | +$5K | ﹤0.01% | 933 |
|
|
2017
Q2 | – | Sell |
-32
| Closed | -$1K | – | 454 |
|
|
2017
Q1 | $1K | Buy |
+32
| New | +$1K | ﹤0.01% | 451 |
|
|
2014
Q4 | – | Sell |
-280
| Closed | -$3K | – | 148 |
|
|
2014
Q3 | $3K | Buy |
+280
| New | +$3K | 0.01% | 275 |
|
|
2014
Q2 | – | Sell |
-272
| Closed | -$3K | – | 144 |
|
|
2014
Q1 | $3K | Buy |
+272
| New | +$3K | 0.01% | 141 |
|
|
2013
Q4 | – | Sell |
-3,992
| Closed | -$28K | – | 232 |
|
|
2013
Q3 | $28K | Buy |
+3,992
| New | +$28K | 0.12% | 110 |
|